Carillon Tower Advisers’s DexCom DXCM Stock Holding History

Carillon Tower Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$14.3M	Buy	155,080 +102,680	+196%	+$9.17M	0.09%	297
2020 Q3	$5.4M	Sell	52,400 -754,688	-94%	-$78.8M	0.07%	325
2020 Q2	$81.8M	Sell	807,088 -372,216	-32%	-$33.3M	0.63%	37
2020 Q1	$75.3M	Buy	1,179,304 +52,400	+5%	+$3.26M	0.74%	25
2019 Q4	$61.6M	Hold	1,126,904	–	–	0.41%	76
2019 Q3	$42M	Hold	1,126,904	–	–	0.29%	122
2019 Q2	$42.2M	Buy	1,126,904 +147,592	+15%	+$4.64M	0.29%	119
2019 Q1	$29.2M	Hold	979,312	–	–	0.21%	182
2018 Q4	$29.3M	Buy	+979,312	New	+$31.1M	0.25%	161

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carillon Tower Advisers's DXCM Position: Q4 2020 in Review

Carillon Tower Advisers increased its DexCom (DXCM) stake by 196% in Q4 2020, buying an estimated $9.17M and bringing the position to 155,080 shares worth $14.3M. The position accounts for 0.09% of the portfolio, ranked #297.

Carillon Tower Advisers first reported a position in DXCM in Q4 2018 and has held it in 9 quarters since. The position peaked at $81.8M in Q2 2020. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

Carillon Tower Advisers held 155,080 shares of DexCom worth $14.3M as of Q4 2020.
Carillon Tower Advisers bought 102,680 DexCom shares in Q4 2020, an estimated $9.17M.
DexCom made up 0.09% of Carillon Tower Advisers's portfolio in Q4 2020, its #297 holding.
Carillon Tower Advisers first reported a position in DexCom in Q4 2018 and has held it in 9 quarters since.
Carillon Tower Advisers's DexCom position peaked at $81.8M in Q2 2020.
732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.